Literature DB >> 26753054

Nonenhancing Leptomeningeal Metastases: Imaging Characteristics and Potential Causative Factors.

Vaios Hatzoglou1, Sasan Karimi1, Eli L Diamond2, Eric Lis1, George Krol1, Andrei I Holodny1, Robert J Young1.   

Abstract

The diagnosis of leptomeningeal metastasis (LM) has increased in frequency, as new therapies have lengthened the survival of patients with cancer. Early diagnosis and intervention help improve quality of life and prevent further neurological deterioration in LM. The detection of LM is often established by magnetic resonance imaging examinations, cerebrospinal fluid analysis, or both. We present a series of cases where LM was identified on fluid-attenuated inversion recovery or T2-weighted image but was nonenhancing on the traditionally more sensitive postcontrast T1-weighted sequences. Nonenhancing LM is unusual and not yet fully understood but should be considered in the appropriate clinical context and may become more common with increased utilization of antiangiogenic therapies.

Entities:  

Keywords:  brain neoplasms; imaging; meningeal neoplasms; nervous system neoplasms; techniques

Year:  2016        PMID: 26753054      PMCID: PMC4680901          DOI: 10.1177/1941874415591702

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  14 in total

1.  Science to practice: blood-brain barrier leakage--one size does not fit all.

Authors:  A Gregory Sorensen
Journal:  Radiology       Date:  2010-11       Impact factor: 11.105

Review 2.  Hyperintensity in the subarachnoid space on FLAIR MRI.

Authors:  Stephen L Stuckey; Tony D Goh; Theresa Heffernan; David Rowan
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

Review 3.  Contrast media and the brain. The basis of CT and MR imaging enhancement.

Authors:  M R Sage; A J Wilson; R Scroop
Journal:  Neuroimaging Clin N Am       Date:  1998-08       Impact factor: 2.264

4.  Leptomeningeal metastases in the MRI era.

Authors:  J L Clarke; H R Perez; L M Jacks; K S Panageas; L M Deangelis
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

5.  Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study.

Authors:  M E Olson; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1974-02

Review 6.  Patterns of contrast enhancement in the brain and meninges.

Authors:  James G Smirniotopoulos; Frances M Murphy; Elizabeth J Rushing; John H Rees; Jason W Schroeder
Journal:  Radiographics       Date:  2007 Mar-Apr       Impact factor: 5.333

7.  MR imaging of leptomeningeal metastases: comparison of three sequences.

Authors:  Sanjay K Singh; Norman E Leeds; Lawrence E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

Review 8.  Leptomeningeal disease.

Authors:  Morris D Groves
Journal:  Neurosurg Clin N Am       Date:  2011-01       Impact factor: 2.509

9.  In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach.

Authors:  Dean B Percy; Emeline J Ribot; Yuhua Chen; Catherine McFadden; Carmen Simedrea; Patricia S Steeg; Ann F Chambers; Paula J Foster
Journal:  Invest Radiol       Date:  2011-11       Impact factor: 6.016

10.  Nonenhancing brain metastases.

Authors:  Sasan Karimi; Eric Lis; Saba Gilani; Nicholas D'Ambrosio; Andrei Holodny
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

View more
  7 in total

Review 1.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

2.  Leptomeningeal dissemination of low-grade neuroepithelial CNS tumors in adults: a 15-year experience.

Authors:  Philipp Karschnia; Frank J Barbiero; Michaela H Schwaiblmair; Leon D Kaulen; Joseph M Piepmeier; Anita J Huttner; Kevin P Becker; Robert K Fulbright; Joachim M Baehring
Journal:  Neurooncol Pract       Date:  2019-07-06

3.  Gadobutrol-enhanced magnetic resonance imaging of meningeal carcinomatosis: case report with emphasis on early diagnosis.

Authors:  Xinfa Pan; Yongfu Lu; Liang Wen; Xiujue Zheng; Yuehui Ma
Journal:  BMC Neurol       Date:  2016-09-01       Impact factor: 2.474

4.  Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics.

Authors:  Lena Bönig; Nora Möhn; Jonas Ahlbrecht; Ulrich Wurster; Peter Raab; Wolfram Puppe; Kurt-Wolfram Sühs; Martin Stangel; Thomas Skripuletz; Philipp Schwenkenbecher
Journal:  Front Neurol       Date:  2019-08-20       Impact factor: 4.003

Review 5.  FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review.

Authors:  Koichi Mitsuya; Yoko Nakasu; Shoichi Deguchi; Kensei Shirata; Koiku Asakura; Kazuaki Nakashima; Masahiro Endo; Toshiaki Takahashi; Nakamasa Hayashi
Journal:  Cancer Imaging       Date:  2020-11-23       Impact factor: 3.909

6.  Polymeric Micelle of A₃B-Type Lactosome as a Vehicle for Targeting Meningeal Dissemination.

Authors:  Kensuke Kurihara; Motoki Ueda; Isao Hara; Eiichi Ozeki; Kaori Togashi; Shunsaku Kimura
Journal:  Nanomaterials (Basel)       Date:  2018-01-31       Impact factor: 5.076

7.  Intra-operative cerebrospinal fluid sampling versus post-operative lumbar puncture for detection of leptomeningeal disease in malignant paediatric brain tumours.

Authors:  Sharon Y Y Low; Chen Min Wei; Kenneth T E Chang; Chan Yiong Huak; Ng Lee Ping; Seow Wan Tew; David C Y Low
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.